Study to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years With Influenza

Phase 3 Terminated 98 enrolled Nanjing Zenshine Pharmaceuticals

RandomizedParallel-groupQuadruple-blindTreatment

Summary

A multicenter, randomized, double-blind, positive controlled, phase III trial to evaluate the safety and efficacy of ZX-7101A tablets versus oseltamivir phosphate suspension in children aged ≥5 years and \< 12 years with uncomplicated influenza.

Timeline

Start: 2024-10-31
Primary completion: 2025-07-15
Completion: 2025-07-15

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Oseltamivir	Small molecule	0.36 g	Oral
Subject	ZX-7101A	Unknown	20 mg	Oral

Study to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years With Influenza

Summary

Timeline

Drugs

Indications